These results highlighted the prominent places of GDH1 and GOT1 in the glutaminolysis process of HCC, suggesting that novel therapeutic approaches based on such two enzymes may be more beneficial to HCC treatment. Here, GLUD1 is linked to hepatocellular carcinoma.